Diabetes Blockade of Sevoflurane Postconditioning Is Not Restored by Insulin in the Rat Heart
- 1 June 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 114 (6) , 1364-1372
Abstract
Background: The possibility of restoring sevoflurane postconditioning (sevo-postC) cardioprotection in diabetic animals is uncertain. We hypothesized that attenuation of myocardial injury by sevo-postC might be hindered by inhibition of signal transducer and activator of transcription (STAT) 3-regulated activity of phosphatidylinositol 3-kinase (PI3K) in diabetic animals. To determine whether postC cardioprotection can be restored by normoglycemia, we treated rats with insulin. Methods: Diabetic or nondiabetic rats were randomly subjected to 30-min ischemia/reperfusion, with ischemic postC or sevo-postC, with and without mitochondrial adenosine triphosphate-dependent potassium channel blocker 5-hydroxy decanoate sodium and PI3K antagonist wortmannin. The infarct area, phosphorylated STAT3, and apoptosis were examined. Studies were repeated after insulin treatment. Results: Ischemic postC and sevo-postC significantly reduced infarct size by 50% in the nondiabetic rats (P < 0.002), a phenomenon completely reversed by 5-hydroxy decanoate sodium and wortmannin. Diabetes mellitus blocked the protective effect of postC, and insulin treatment to achieve normoglycemia did not restore cardioprotection. Phosphorylated STAT3 nuclear retention was significantly increased after ischemia-reperfusion and was further enhanced in response to ischemic postC (P < 0.05) but was significantly reduced in diabetic rats (by 43%; P < 0.01). Conclusions: The effective reduction in infarct size and apoptosis in the nondiabetic rat heart by postC was completely abrogated in diabetic rats. This inhibition is not relieved by insulin-induced normoglycemia. The PI3K pathway and mitochondrial adenosine triphosphate-dependent potassium channel activation are involved in the mechanism of postC. In diabetic rats, STAT3 activation was strongly reduced, as was postC cardioprotection, suggesting that the inability of insulin to restore postC may be attributed to diabetes-induced STAT3-mediated inhibition of PI3K signaling.Keywords
This publication has 38 references indexed in Scilit:
- Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia–reperfusionJournal of Anesthesia, 2010
- Diabetic cardiomyopathy – a distinct disease?Best Practice & Research Clinical Endocrinology & Metabolism, 2009
- Insulin resistance and heart failureCurrent Heart Failure Reports, 2009
- Isoflurane Protects against Myocardial Infarction during Early Reperfusion by Activation of Phosphatidylinositol-3-Kinase Signal Transduction: Evidence for Anesthetic-induced Postconditioning in RabbitsAnesthesiology, 2005
- Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanismsBritish Journal of Anaesthesia, 2003
- Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioningAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivoPflügers Archiv - European Journal of Physiology, 2003
- Isoflurane Mimics Ischemic Preconditioning via Activation of KATPChannelsAnesthesiology, 1997
- Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide studyAmerican Heart Journal, 1995
- The diabetic heart: metabolic causes for the development of a cardiomyopathyCardiovascular Research, 1992